Biblio
“Meningeal lymphatics affect microglia responses and anti-Aβ immunotherapy.”, Nature, vol. 593, no. 7858, pp. 255-260, 2021.
, “A genome-wide scan for common variants affecting the rate of age-related cognitive decline.”, Neurobiol Aging, vol. 33, no. 5, pp. 1017.e1-15, 2012.
, “TREM2 brain transcript-specific studies in AD and TREM2 mutation carriers.”, Mol Neurodegener, vol. 14, no. 1, p. 18, 2019.
, “A single-nuclei RNA sequencing study of Mendelian and sporadic AD in the human brain.”, Alzheimers Res Ther, vol. 11, no. 1, p. 71, 2019.
, “Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease.”, Mol Psychiatry, 2021.
, “Genetic risk for schizophrenia and psychosis in Alzheimer disease.”, Mol Psychiatry, vol. 23, no. 4, pp. 963-972, 2018.
, “A potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin.”, Neurobiol Aging, vol. 37, pp. 208.e1-208.e9, 2016.
, “The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk.”, Sci Transl Med, vol. 11, no. 505, 2019.
, “Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers.”, Acta Neuropathol, vol. 133, no. 5, pp. 839-856, 2017.
, “Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score.”, PLoS Med, vol. 14, no. 3, p. e1002258, 2017.
, “Genetic overlap between Alzheimer's disease and Parkinson's disease at the MAPT locus.”, Mol Psychiatry, vol. 20, no. 12, pp. 1588-95, 2015.
, “Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease.”, Circulation, vol. 131, no. 23, pp. 2061-2069, 2015.
, “Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk.”, Alzheimers Dement, vol. 12, no. 2, pp. 121-129, 2016.
, “Polymorphisms in the PON gene cluster are associated with Alzheimer disease.”, Hum Mol Genet, vol. 15, no. 1, pp. 77-85, 2006.
, “Elevated amyloid beta protein (Abeta42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene.”, Hum Mol Genet, vol. 14, no. 3, pp. 447-60, 2005.
, “Fine mapping of the chromosome 10q11-q21 linkage region in Alzheimer's disease cases and controls.”, Neurogenetics, vol. 11, no. 3, pp. 335-48, 2010.
, “SORL1 variants across Alzheimer's disease European American cohorts.”, Eur J Hum Genet, vol. 24, no. 12, pp. 1828-1830, 2016.
, “Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer Disease.”, PLoS Genet, vol. 13, no. 11, p. e1007045, 2017.
, “Genetic variation within endolysosomal system is associated with late-onset Alzheimer's disease.”, Brain, vol. 141, no. 9, pp. 2711-2720, 2018.
, “Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals.”, JAMA Neurol, vol. 72, no. 11, pp. 1313-23, 2015.
, “Genetic association of low density lipoprotein receptor and Alzheimer's disease.”, Neurobiol Aging, vol. 26, no. 1, pp. 1-7, 2005.
, “Risk of dementia among white and African American relatives of patients with Alzheimer disease.”, JAMA, vol. 287, no. 3, pp. 329-36, 2002.
, “Developmentally stable whole-brain volume reductions and developmentally sensitive caudate and putamen volume alterations in those with attention-deficit/hyperactivity disorder and their unaffected siblings.”, JAMA Psychiatry, vol. 72, no. 5, pp. 490-9, 2015.
, “Next generation sequencing techniques in neurological diseases: redefining clinical and molecular associations.”, Hum Mol Genet, vol. 23, no. R1, pp. R47-53, 2014.
, “Genomics in neurological disorders.”, Genomics Proteomics Bioinformatics, vol. 12, no. 4, pp. 156-63, 2014.
,